| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-14 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-13 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-13 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-11 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-10 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |